Mostrando 3 resultados de: 3
A randomized, double blind, cross-over, placebo-controlled clinical trial to assess the effects of Candesartan on the insulin sensitivity on non diabetic, non hypertense subjects with dysglyce mia and abdominal obesity. "ARAMIA"
ArticleAbstract: Background: The raising prevalence of type-2 diabetes mellitus and obesity has been recognized as aPalabras claves:Autores:Lahera V., Márquez G.A., PATRICIO LOPEZ -JARAMILLO, Pradilla L.P., Rueda-Clausen C.F., Silva-Sieger F.A.Fuentes:googlescopusAged garlic extract improves adiponectin levels in subjects with metabolic syndrome: A double-blind, placebo-controlled, randomized, crossover study
ArticleAbstract: Background. Garlic (Allium sativum) has been shown to have important benefits in individuals at highPalabras claves:Autores:Camacho-López P.A., De Las Heras N., García-Gómez R.G., Gomez-Arbelaez D., Lahera V., Oubiña P., PATRICIO LOPEZ -JARAMILLO, Rodríguez Y.A., Valero-Muñoz M.Fuentes:googlescopusEpidemic of cardiometabolic diseases: A Latin American point of view
ReviewAbstract: Poor early nutrition has varying effects on subsequent cardiometabolic disease (CMD) rates. Fetal anPalabras claves:abdominal obesity, Cardiovascular disease, epigenetic, Insulin Resistance, Latin America, Low-degree inflammationAutores:Lahera V., López-López J.P., PATRICIO LOPEZ -JARAMILLOFuentes:googlescopus